DexCom has been a great trade. While the S&P 500 was flat, the stock price has climbed by 15.6% to $87 per share. This was ...

As the U.S. stock market navigates mixed performance amid rising Treasury yields and a recent credit rating downgrade, investors are keenly observing opportunities that may have been overlooked. In ...

In earnings calls, diabetes tech companies had less to say about tariffs and focused more on future growth.

DexCom, Inc. DXCM is well-poised for growth in the coming quarters, backed by its strong product portfolio. A strong ...

Dexcom Inc. defeated investor allegations the glucose monitor maker exaggerated its ability to tap into the market of ...

DexCom Inc. closed 34.58% short of its 52-week high of $132.26, which the company reached on May 17th.

Shares of DexCom Inc. DXCM shed 1.11% to $84.11 Tuesday, on what proved to be an all-around mixed trading session for the ...

Ken Griffin, the founder of Citadel, is an influential albeit controversial figure in the investment industry.

Dexcom (Nasdaq: DXCM) today announced a significant internal promotion for a longtime member of its leadership team.

DexCom, Inc. (NASDAQ: DXCM), the global leader in real-time continuous glucose biosensing, today announced the promotion of ...

Connacht fought back from 14 points down to draw level in the second half but ultimately fell to a fifth successive United ...

Edinburgh hold an edge in this fixture with 20 wins from 37 meetings which includes 15 Connacht triumphs and two draws.